Gopaldas Visram And Company Limited

Gopaldas Visram And Company Limited (India) has no DMF, CEP or site registration linked in our records. 12 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Gopaldas Visram And Company Limited: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/gopaldas-visram-and-company-limited

Overview

Gopaldas Visram And Company Limited is a pharmaceutical company headquartered in Mumbai, India.

FDA compliance signals

12 FDA enforcement records linked to this company.

  • warning_letter2026-06-02

    FDA Warning Letter (drug product)

  • 4832025-01-24

    Computer control of master formula records

  • 4832025-01-24

    Procedures not in writing, fully followed

  • 4832025-01-24

    Cleaning/maintenance records not kept

  • 4832025-01-24

    Procedure Deviations Recorded and Justified

  • 4832025-01-24

    Components withheld from use pending release

  • 4832017-12-01

    Computer control of master formula records

  • 4832017-12-01

    Control procedures to monitor and validate performance

  • 4832017-12-01

    Procedures not in writing, fully followed

  • 4832017-12-01

    Washing and toilet facilities not provided and accessible

  • 4832017-12-01

    Lack of written stability program

  • 4832017-12-01

    Test methods

For suppliers

Is this Gopaldas Visram And Company Limited?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.